855789-56-9 Usage
General Description
1,2,4-Triazolo[4,3-a]pyridine, 3-(chloroMethyl)- is a chemical compound that belongs to the triazolopyridine family and contains a chloromethyl substituent. It has potential applications in the pharmaceutical and agrochemical industries due to its diverse biological activities, including antiviral, antibacterial, and antifungal properties. The chloromethyl group also provides a reactive site for further chemical modifications, making it a valuable building block for the synthesis of more complex molecules. Additionally, its unique molecular structure gives it potential as a lead compound for drug discovery and development. However,
Check Digit Verification of cas no
The CAS Registry Mumber 855789-56-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,5,7,8 and 9 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 855789-56:
(8*8)+(7*5)+(6*5)+(5*7)+(4*8)+(3*9)+(2*5)+(1*6)=239
239 % 10 = 9
So 855789-56-9 is a valid CAS Registry Number.
855789-56-9Relevant articles and documents
THERAPEUTIC COMPOUNDS
-
Paragraph 00357-00358, (2020/06/10)
The present invention relates to compounds that are Nrf2 activators. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with Nrf2 activation.
NOVEL 2-(PIPERAZIN-1-YL)- AND 2-([1,4]DIAZEPAN-1-YL)- IMIDAZO[4,5-D]PYRIDAZIN-4-ONE, PRODUCTION AND USE THEREOF AS MEDICAMENT FOR THE TREATMENT OF DIABETES MELLITUS
-
Page/Page column 24, (2010/02/12)
The invention relates to substituted imidazo[4,5-d]pyridazin-4-ones of general formula (I), in which R1 to R3 and n are as defined in claims 1 to 8, the tautomers, enantiomers, diastereomers, mixtures and salts thereof which have useful pharmacological properties, in particular, an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
